Enter actual weight
Use kilograms or pounds. Confirm the measured or most reliable current weight.
Adult airway medication reference
Calculate weight-based adult rapid sequence intubation drug doses for ketamine, etomidate, propofol, rocuronium, and succinylcholine—with practical safety notes for medication selection and verification.
Clinical reference only. RSI requires airway expertise, continuous monitoring, resuscitation readiness, and an immediate post-intubation plan. Verify every dose against the patient, medication label, concentration, and local protocol.
Adult rapid sequence intubation
Enter actual body weight to view reference doses. Always choose one induction agent and one paralytic—not every medication shown.
Adult reference only. Obesity and specific agents may require a different dosing scalar.
2026 evidence check. Reviewed against the January 2026 ACEP adult airway policy, current SCCM adult RSI guidance, a 2025 AANP practice brief, and current DailyMed prescribing information. Prepared by PulmTools Editorial Team.
Adult quick reference
These commonly referenced IV dose ranges support rapid sequence intubation planning. The calculator uses the specific reference dose shown in the fourth column; patient physiology, obesity, contraindications, and local protocols can change the appropriate dose.
| Medication | Role | Reference range | Calculator dose | Key context |
|---|---|---|---|---|
| Ketamine | Induction | 1–2 mg/kg IV | 2 mg/kg | Individualize for physiology and administration rate. |
| Etomidate | Induction | 0.2–0.3 mg/kg IV | 0.3 mg/kg | Usual labeled induction dose; labeling permits a wider individualized range. |
| Propofol | Induction | 1–2 mg/kg IV | 1.5 mg/kg | Avoid in ED patients at increased risk for post-intubation hypotension. |
| Rocuronium | Paralytic | 0.6–1.2 mg/kg IV | 1.2 mg/kg | Upper end of the labeled RSI range; anticipate prolonged paralysis. |
| Succinylcholine | Paralytic | 1–1.5 mg/kg IV | 1.5 mg/kg | Current practice range; screen carefully for contraindications. |
How it works
Weight-based RSI doses are calculated by multiplying the selected dose in mg/kg by the patient’s dosing weight in kilograms. This tool uses actual body weight as the initial input and displays reference amounts—not a medication order.
Use kilograms or pounds. Confirm the measured or most reliable current weight.
Select one induction agent and one neuromuscular blocker based on physiology and contraindications.
Perform an independent check of patient, drug, concentration, dose, route, allergies, and local protocol.
Ketamine and etomidate are commonly used when peri-intubation hypotension is a concern. The January 2026 ACEP adult endotracheal-intubation policy recommends ketamine or etomidate to reduce that risk in emergency-department patients.
Propofol can produce hypotension and cardiorespiratory depression. ACEP advises avoiding it as an induction or coinduction drug in ED patients at increased risk for post-intubation hypotension.
Rocuronium 0.6–1.2 mg/kg is labeled for rapid sequence intubation. The current SCCM adult RSI guideline supports either rocuronium or succinylcholine when succinylcholine has no known contraindication. Higher rocuronium doses tend to favor faster onset but also leave a longer period of paralysis, making prompt post-intubation analgesia and sedation essential.
Succinylcholine 1–1.5 mg/kg is commonly listed for adult RSI in current clinical practice references; its prescribing information describes a lower adult intubation range. It has a shorter duration but important contraindications and warnings. Screen carefully for conditions that raise the risk of hyperkalemia, rhabdomyolysis, malignant hyperthermia, or prolonged blockade.
After the airway is secured
Tidal volume uses predicted body weight derived from height and sex—not the actual body weight entered for this drug calculator. The ARDSNet Assistant keeps that workflow and its distinct safety logic in the right place.
Common questions
RSI usually combines one induction agent with one neuromuscular blocker. Ketamine and etomidate are common induction choices; rocuronium and succinylcholine are common paralytic choices. Propofol may be considered in selected hemodynamically stable patients.
A commonly referenced adult IV induction dose is 1–2 mg/kg. This calculator displays 2 mg/kg. Dose, route, administration rate, and patient physiology must be considered before use.
The usual adult induction dose in etomidate prescribing information is 0.3 mg/kg IV. The labeled range is 0.2–0.6 mg/kg and dosing must be individualized.
Rocuronium prescribing information lists 0.6–1.2 mg/kg for rapid sequence intubation. This calculator displays 1.2 mg/kg, which is the upper end of that labeled range and is commonly selected when rapid onset is the priority.
Current adult RSI practice references commonly use 1–1.5 mg/kg IV. This calculator displays 1.5 mg/kg. FDA labeling for routine adult tracheal intubation describes a lower 0.3–1.1 mg/kg range, so clinicians should follow medication-specific guidance and local RSI protocols.
This tool starts with actual body weight. Obesity may change the appropriate dosing scalar for selected medications, so clinicians should verify drug-specific guidance, patient factors, and local pharmacy or airway protocols.
No. Drug dose and tidal volume use different inputs and weight concepts. Initial lung-protective tidal volume should be based on predicted body weight from height and sex, not actual body weight. Use the linked ARDSNet Assistant for that calculation.
Dose information is grounded in current U.S. prescribing information and adult emergency-airway guidance. Evidence last checked August 15, 2026.